NLSCX | SAOCX | NLSCX / SAOCX | |
Total Expense Ratio | 2.43 | 2.46 | 99% |
Annual Report Gross Expense Ratio | 2.43 | 2.60 | 93% |
Fund Existence | 14 years | 22 years | - |
Gain YTD | 5.936 | -3.025 | -196% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 2500 | 40% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 7.54B | 35.4M | 21,294% |
Annual Yield % from dividends | 0.00 | 0.00 | - |
Returns for 1 year | 8.83 | -4.98 | -177% |
Returns for 3 years | 16.55 | 22.03 | 75% |
Returns for 5 years | 18.83 | 21.37 | 88% |
Returns for 10 years | 43.23 | 8.48 | 510% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
FBIOX | 21.16 | 0.32 | +1.54% |
Fidelity Select Biotechnology | |||
RTISX | 12.28 | 0.07 | +0.57% |
Russell Inv Multifactor Intl Eq S | |||
GTLOX | 21.63 | 0.11 | +0.51% |
Glenmede Disciplined US Eq Ptf | |||
NPFFX | 71.29 | 0.33 | +0.47% |
American Funds New Perspective F1 | |||
VAIGX | 23.46 | N/A | N/A |
Vanguard Advice Select Intl Gr Admiral |